NO158416C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme pentandisyrederivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme pentandisyrederivater.

Info

Publication number
NO158416C
NO158416C NO830981A NO830981A NO158416C NO 158416 C NO158416 C NO 158416C NO 830981 A NO830981 A NO 830981A NO 830981 A NO830981 A NO 830981A NO 158416 C NO158416 C NO 158416C
Authority
NO
Norway
Prior art keywords
pentandic
preparation
therapeutically effective
acid derivatives
analogue procedure
Prior art date
Application number
NO830981A
Other languages
English (en)
Norwegian (no)
Other versions
NO830981L (no
NO158416B (no
Inventor
Harman Smith Lowrie
John Stanislaus Baran
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO830981L publication Critical patent/NO830981L/no
Publication of NO158416B publication Critical patent/NO158416B/no
Publication of NO158416C publication Critical patent/NO158416C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/31—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20—Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/26—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/29—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO830981A 1982-03-22 1983-03-21 Analogifremgangsmaate for fremstilling av terapeutisk virksomme pentandisyrederivater. NO158416C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36054382A 1982-03-22 1982-03-22

Publications (3)

Publication Number Publication Date
NO830981L NO830981L (no) 1983-09-23
NO158416B NO158416B (no) 1988-05-30
NO158416C true NO158416C (no) 1988-09-07

Family

ID=23418429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830981A NO158416C (no) 1982-03-22 1983-03-21 Analogifremgangsmaate for fremstilling av terapeutisk virksomme pentandisyrederivater.

Country Status (12)

Country Link
EP (1) EP0089674B1 (Direct)
JP (1) JPS58172341A (Direct)
AU (1) AU564466B2 (Direct)
CA (1) CA1249268A (Direct)
DE (1) DE3361607D1 (Direct)
DK (1) DK162713C (Direct)
ES (1) ES520799A0 (Direct)
IE (1) IE54626B1 (Direct)
NO (1) NO158416C (Direct)
NZ (1) NZ203637A (Direct)
PT (1) PT76419B (Direct)
ZA (1) ZA831983B (Direct)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554359A (en) * 1984-01-09 1985-11-19 G. D. Searle & Co. 3-Substituted pentanedioic acids and derivatives thereof
US5055613A (en) * 1988-02-18 1991-10-08 G. D. Searle & Co. Metabolites of pentanedioic acid derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3112249A (en) * 1962-12-10 1963-11-26 Commw Engineering Co Of Ohio Process of splitting steroids
US3629449A (en) * 1968-04-22 1971-12-21 Majid Siddiqi Process of combatting hypercholesterolemia
US3818080A (en) * 1972-07-20 1974-06-18 Searle & Co 3-hydroxy-3-substituted glutaric acid derivatives
FR2244485A1 (en) * 1973-08-06 1975-04-18 Aries Robert Lithium dicarboxylic acid salts - in compositions for treatment of psychoses, esp. manic depression

Also Published As

Publication number Publication date
DK125483A (da) 1983-09-23
PT76419A (en) 1983-04-01
DK162713B (da) 1991-12-02
JPH0525866B2 (Direct) 1993-04-14
CA1249268A (en) 1989-01-24
NZ203637A (en) 1986-08-08
ES8505330A1 (es) 1985-05-16
IE54626B1 (en) 1989-12-20
NO830981L (no) 1983-09-23
AU564466B2 (en) 1987-08-13
DK125483D0 (da) 1983-03-18
PT76419B (en) 1985-12-09
EP0089674A1 (en) 1983-09-28
ZA831983B (en) 1984-11-28
NO158416B (no) 1988-05-30
ES520799A0 (es) 1985-05-16
DE3361607D1 (de) 1986-02-06
EP0089674B1 (en) 1985-12-27
IE830604L (en) 1983-09-22
JPS58172341A (ja) 1983-10-11
DK162713C (da) 1992-04-21
AU1261783A (en) 1983-09-29

Similar Documents

Publication Publication Date Title
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO832701L (no) Fremgangsmaate til fremstilling av metylen-difosfonsyre-derivater.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO820287L (no) Fremgangsmaate for fremstilling av isocyanursyre-derivater
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO165397C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO864110D0 (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO159291C (no) Fremgangsmaate for fremstilling av gamma-substituerte 3(r)-hydroxysmoersyrederivater.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO821882L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater
NO160203C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fenotiazin-forbindelser.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO156408C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO160712C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-forbindelser.